Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).

NCT ID: NCT04303780

Last Updated: 2025-10-14

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

PHASE3

Total Enrollment

345 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-06-04

Study Completion Date

2026-02-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A Phase 3 Study to Compare AMG 510 with Docetaxel in Non Small Cell Lung Cancer (NSCLC) subjects with KRAS p. G12c mutation

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

KRAS p, G12c Mutated /Advanced Metastatic NSCLC

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

AMG 510

Group Type EXPERIMENTAL

AMG 510

Intervention Type DRUG

21 day cycles

Docetaxel

Group Type ACTIVE_COMPARATOR

Docetaxel

Intervention Type DRUG

21 day cycles

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

AMG 510

21 day cycles

Intervention Type DRUG

Docetaxel

21 day cycles

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men or women greater than or equal to 18 years old.
* ECOG ≤ 1
* Pathologically documented, previously treated, locally-advanced and unresectable or metastatic NSCLC with KRAS p.G12C mutation confirmed through central testing or have documentation of KRAS p.G12C mutation through Amgen Study 20190294 prior to enrollment

Exclusion Criteria

* Active brain metastases
* Myocardial infarction within 6 months of study day 1
* Gastrointestinal (GI) tract disease causing the inability to take oral medication
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Amgen

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

MD

Role: STUDY_DIRECTOR

Amgen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pacific Cancer Medical Center Inc

Anaheim, California, United States

Site Status

City of Hope National Medical Center

Duarte, California, United States

Site Status

Pacific Shores Medical Group Long Beach

Long Beach, California, United States

Site Status

University of California Los Angeles

Los Angeles, California, United States

Site Status

University of California Los Angeles

Los Angeles, California, United States

Site Status

University of California at Davis Medical Center

Sacramento, California, United States

Site Status

Ridley Tree Cancer Center

Santa Barbara, California, United States

Site Status

University of California San Francisco Mission Hall

Stanford, California, United States

Site Status

Harbor University of California Los Angeles Medical Center

Torrance, California, United States

Site Status

Rocky Mountain Cancer Centers

Denver, Colorado, United States

Site Status

Danbury Hospital

Norwalk, Connecticut, United States

Site Status

Medical Oncology Hematology Consultants Helen F Graham Cancer Center

Newark, Delaware, United States

Site Status

Washington Cancer Institute at MedStar Washington Hospital

Washington D.C., District of Columbia, United States

Site Status

Florida Cancer Specialists - Fort Myers

Fort Myers, Florida, United States

Site Status

Memorial Regional Hospital

Hollywood, Florida, United States

Site Status

Florida Cancer Specialists Research North

St. Petersburg, Florida, United States

Site Status

Florida Cancer Specialists Research Panhandle

Tallahassee, Florida, United States

Site Status

Emory University

Atlanta, Georgia, United States

Site Status

Northside Hospital, Incorporated

Atlanta, Georgia, United States

Site Status

Affiliated Oncologists, LLC

North Chicago, Illinois, United States

Site Status

Fort Wayne Medical Oncology and Hematology

Fort Wayne, Indiana, United States

Site Status

Willis Knighton Cancer Center

Shreveport, Louisiana, United States

Site Status

Maryland Oncology Hematology PA

Clinton, Maryland, United States

Site Status

New York Cancer and Blood Specialists

Lowell, Massachusetts, United States

Site Status

University of Michigan

Ann Arbor, Michigan, United States

Site Status

Center for Oncology Clinical Trials

Grand Rapids, Michigan, United States

Site Status

Minnesota Oncology Hematology PA

Minneapolis, Minnesota, United States

Site Status

HCA Midwest Health Kansas City

Kansas City, Missouri, United States

Site Status

Comprehensive Cancer Centers of Nevada

Las Vegas, Nevada, United States

Site Status

Summit Medical Group

Florham Park, New Jersey, United States

Site Status

New York Oncology Hematology, PC

Albany, New York, United States

Site Status

United States Oncology Regulatory Affairs Corporate Office

Albany, New York, United States

Site Status

Northwell Health Monter Cancer Center

Lake Success, New York, United States

Site Status

Montefiore Einstein Center for Cancer Care

The Bronx, New York, United States

Site Status

James J Peters VA Medical Center

The Bronx, New York, United States

Site Status

Wake Forest Baptist Health

Winston-Salem, North Carolina, United States

Site Status

Oncology Hematology Care Inc

Cincinnati, Ohio, United States

Site Status

Northwest Cancer Specialists - Vancouver

Portland, Oregon, United States

Site Status

Charleston Oncology

Charleston, South Carolina, United States

Site Status

Saint Francis Hospital, Inc

Greenville, South Carolina, United States

Site Status

Tennessee Oncology PLLC

Chattanooga, Tennessee, United States

Site Status

Tennessee Cancer Specialists

Knoxville, Tennessee, United States

Site Status

Tennessee Oncology

Nashville, Tennessee, United States

Site Status

Texas Oncology-Bedford

Bedford, Texas, United States

Site Status

Texas Oncology Baylor

Dallas, Texas, United States

Site Status

UT Southwestern Medical Center

Dallas, Texas, United States

Site Status

The Center for Cancer and Blood Disorders

Fort Worth, Texas, United States

Site Status

Valley Cancer Associates

Harlingen, Texas, United States

Site Status

University of Texas MD Anderson Cancer Center

Houston, Texas, United States

Site Status

US Oncology Research Investigational Products Center

Irving, Texas, United States

Site Status

Hope Cancer Center

Tyler, Texas, United States

Site Status

Intermountain Medical Center

Murray, Utah, United States

Site Status

Virginia Cancer Specialists, PC

Fairfax, Virginia, United States

Site Status

Virginia Oncology Associates

Norfolk, Virginia, United States

Site Status

Blacktown Hospital

Blacktown, New South Wales, Australia

Site Status

Chris OBrien Lifehouse

Camperdown, New South Wales, Australia

Site Status

St George Hospital

Kogarah, New South Wales, Australia

Site Status

Liverpool Hospital

Liverpool, New South Wales, Australia

Site Status

Prince Charles Hospital

Chermside, Queensland, Australia

Site Status

Princess Alexandra Hospital

Woolloongabba, Queensland, Australia

Site Status

The Queen Elizabeth Hospital

Woodville South, South Australia, Australia

Site Status

Monash Medical Centre

Clayton, Victoria, Australia

Site Status

Peter MacCallum Cancer Centre

Melbourne, Victoria, Australia

Site Status

St John of God Healthcare

Subiaco, Western Australia, Australia

Site Status

Institute Jules Bordet

Brussels, , Belgium

Site Status

Universite Catholique de Louvain Cliniques Universitaires Saint Luc

Brussels, , Belgium

Site Status

Grand Hopital de Charleroi

Charleroi, , Belgium

Site Status

Universitair Ziekenhuis Antwerpen

Edegem, , Belgium

Site Status

Universitair Ziekenhuis Gent

Ghent, , Belgium

Site Status

Universitair Ziekenhuis Leuven - Campus Gasthuisberg

Leuven, , Belgium

Site Status

Centre Hospitalier Universitaire de Liege

Liège, , Belgium

Site Status

AZ Delta Campus Rumbeke

Roeselare, , Belgium

Site Status

Algemeen Ziekenhuis Nikolaas Campus Sint Niklaas

Sint-Niklaas, , Belgium

Site Status

Hospital de Caridade de Ijui

Ijuí, Rio Grande do Sul, Brazil

Site Status

Hospital Sao Lucas da Pontificia Universidade Catolica do Rio Grande do Sul

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Sociedade Beneficente de Senhoras Hospital Sirio Libanes

São Paulo, São Paulo, Brazil

Site Status

Beneficencia Portuguesa de Sao Paulo

São Paulo, São Paulo, Brazil

Site Status

Oncologia Rede D´Or

São Paulo, São Paulo, Brazil

Site Status

Hospital Israelita Albert Einstein

São Paulo, São Paulo, Brazil

Site Status

Hospital de Base de Sao Jose do Rio Preto

São José Do Rio Preto, São Paulo, Brazil

Site Status

Fundacao Antonio Prudente - Hospital A C Camargo

São Paulo, São Paulo, Brazil

Site Status

Centro de Tratamento de Tumores Botafogo

Rio de Janeiro, , Brazil

Site Status

Instituto Coi

Rio de Janeiro, , Brazil

Site Status

Tom Baker Cancer Centre

Calgary, Alberta, Canada

Site Status

Cross Cancer Institute

Edmonton, Alberta, Canada

Site Status

Juravinski Cancer Centre

Hamilton, Ontario, Canada

Site Status

London Health Sciences Centre

London, Ontario, Canada

Site Status

The Ottawa Hospital Cancer Centre

Ottawa, Ontario, Canada

Site Status

Princess Margaret Cancer Centre

Toronto, Ontario, Canada

Site Status

Centre Hospitalier de L'Universite de Montreal Hopital Notre-Dame

Montreal, Quebec, Canada

Site Status

Herlev og Gentofte Hospital

Herlev, , Denmark

Site Status

Rigshospitalet

København, , Denmark

Site Status

Odense Universitetshospital

Odense C, , Denmark

Site Status

Docrates Syopasairaala

Helsinki, , Finland

Site Status

Helsingin Yliopistollinen Keskussairaala

Helsinki, , Finland

Site Status

Oulu University Hospital

Oulu, , Finland

Site Status

Turku University Hospital

Turku, , Finland

Site Status

Centre Hospitalier Regional Universitaire - Hopital Morvan

Brest, , France

Site Status

Centre Hospitalier Intercommunal de Créteil

Créteil, , France

Site Status

Centre Hospitalier Universitaire de Grenoble - Hopital Nord Michallon

Grenoble, , France

Site Status

Centre Hospitalier Universitaire Régional de Lille - Hôpital Albert Calmette

Lille, , France

Site Status

Centre Hospitalier Universitaire de Limoges - Hopital Dupuytren

Limoges, , France

Site Status

Centre Leon Berard

Lyon, , France

Site Status

Centre Hospitalier Universitaire Nord

Marseille, , France

Site Status

Institut Curie

Paris, , France

Site Status

Hopital Cochin

Paris, , France

Site Status

Hopital Bichat Claude Bernard

Paris, , France

Site Status

Hôpital Tenon

Paris, , France

Site Status

Centre Hospitalier Universitaire de Bordeaux - Hopital Haut Leveque

Pessac, , France

Site Status

Centre Hospitalier Lyon Sud

Pierre-Bénite, , France

Site Status

Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou

Rennes, , France

Site Status

Centre Hospitalier de Nantes - Hôpital Nord LaÃ"nnec

Saint-Herblain, , France

Site Status

Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil

Strasbourg, , France

Site Status

Centre Hospitalier Universitaire de Toulouse - Hopital Larrey

Toulouse, , France

Site Status

Gustave Roussy

Villejuif, , France

Site Status

Evangelische Lungenklinik

Berlin, , Germany

Site Status

Charite Universitätsmedizin Berlin, Charité Campus Virchow-Klinikum

Berlin, , Germany

Site Status

Universitaetsklinikum Carl Gustav Carus

Dresden, , Germany

Site Status

Universitätsklinikum Essen

Essen, , Germany

Site Status

Klinikum Esslingen GmbH

Esslingen am Neckar, , Germany

Site Status

Universitätsklinikum Frankfurt/Main

Frankfurt am Main, , Germany

Site Status

Asklepios - Fachkliniken München-Gauting

Gauting, , Germany

Site Status

LungenClinic Grosshansdorf GmbH

Großhansdorf, , Germany

Site Status

Studiengesellschaft Hämato Onkologie Hamburg Prof Laack und Partner

Hamburg, , Germany

Site Status

Universitaetsklinikum Heidelberg

Heidelberg, , Germany

Site Status

Klinikverbund Allgäu

Immenstadt im Allgäu, , Germany

Site Status

Universitatsklinikum Koln

Köln, , Germany

Site Status

Pneumologisch/onkologisch/internistisches Studienzentrum

Leipzig, , Germany

Site Status

Bethanien Krankenhaus

Moers, , Germany

Site Status

Pius-Hospital Oldenburg

Oldenburg, , Germany

Site Status

Agios Savvas Anticancer Hospital

Athens, , Greece

Site Status

Henry Dunant Hospital Center

Athens, , Greece

Site Status

Sotiria General Hospital

Athens, , Greece

Site Status

General Oncology Hospital of Kifissia Agioi Anargyroi

Athens, , Greece

Site Status

Metropolitan Hospital

Athens, , Greece

Site Status

University Hospital of Heraklion

Heraklion - Crete, , Greece

Site Status

University Hospital of Larissa

Larissa, , Greece

Site Status

University Hospital of Patras

Pátrai, , Greece

Site Status

Theagenion Cancer Hospital

Thessaloniki, , Greece

Site Status

Bioclinic of Thessaloniki

Thessaloniki, , Greece

Site Status

Euromedica General Clinic of Thessaloniki

Thessaloniki, , Greece

Site Status

Agios Loukas Clinic

Thessaloniki, , Greece

Site Status

Semmelweis Egyetem

Budapest, , Hungary

Site Status

Orszagos Koranyi Pulmonologiai Intezet

Budapest, , Hungary

Site Status

Veszprem Megyei Tudogyogyintezet

Farkasgyepű, , Hungary

Site Status

Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaz

Gyula, , Hungary

Site Status

Somogy Megyei Kaposi Mor Oktato Korhaz

Kaposvár, , Hungary

Site Status

Borsod-Abauj-Zemplen Megyei Kozponti Korhaz es Egyetemi Oktatokorhaz

Miskolc, , Hungary

Site Status

Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz

Székesfehérvár, , Hungary

Site Status

Szent Borbala Korhaz

Tatabánya, , Hungary

Site Status

Tudogyogyintezet Torokbalint

Törökbálint, , Hungary

Site Status

Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati

Avellino, , Italy

Site Status

IRCCS Istituto Tumori Giovanni Paolo II

Bari, , Italy

Site Status

Azienda Ospedaliera Universitaria di Bologna Policlinico S Orsola Malpighi

Bologna, , Italy

Site Status

Azienda Ospedaliera Universitaria Policlinico Vittorio Emanuele Presidio Ospedaliero G Rodolico

Catania, , Italy

Site Status

Azienda Ospedaliero Universitaria Careggi

Florence, , Italy

Site Status

Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico

Milan, , Italy

Site Status

IRCCS Ospedale San Raffaele

Milan, , Italy

Site Status

Fondazione IRCCS Istituto Nazionale dei Tumori

Milan, , Italy

Site Status

Azienda Ospedaliero Universitaria di Cagliari Policlinico Duilio Casula

Monserrato CA, , Italy

Site Status

Azienda Socio Sanitaria Territoriale di Monza Ospedale San Gerardo

Monza (MB), , Italy

Site Status

Azienda Ospedaliera di Rilievo Nazionale Specialistica dei Colli Monaldi

Napoli, , Italy

Site Status

Azienda Ospedaliera Universitaria San Luigi Gonzaga

Orbassano (TO), , Italy

Site Status

Istituto Oncologico Veneto IRCCS

Padua, , Italy

Site Status

Azienda Unità Sanitaria Locale della Romagna Presidio ospedaliero di Ravenna

Ravenna, , Italy

Site Status

Azienda Ospedaliera Policlinico Umberto I

Roma, , Italy

Site Status

Policlinico Universitario Agostino Gemelli

Roma, , Italy

Site Status

Aichi Cancer Center Hospital

Nagoya, Aichi-ken, Japan

Site Status

Nagoya University Hospital

Nagoya, Aichi-ken, Japan

Site Status

Chiba Cancer Center

Chiba, Chiba, Japan

Site Status

National Cancer Center Hospital East

Kashiwa-shi, Chiba, Japan

Site Status

National Hospital Organization Shikoku Cancer Center

Matsuyama, Ehime, Japan

Site Status

National Hospital Organization Kyushu Cancer Center

Fukuoka, Fukuoka, Japan

Site Status

Kyushu University Hospital

Fukuoka, Fukuoka, Japan

Site Status

Hospital of the University of Occupational and Environmental Health

Kitakyushu-shi, Fukuoka, Japan

Site Status

Chugoku Central Hospital of Japan Mutual Aid Association of Public School Teachers

Fukuyama-shi, Hiroshima, Japan

Site Status

Hiroshima University Hospital

Hiroshima, Hiroshima, Japan

Site Status

National Hospital Organization Hokkaido Cancer Center

Sapporo, Hokkaido, Japan

Site Status

Hyogo Cancer Center

Akashi-shi, Hyōgo, Japan

Site Status

National Hospital Organization Himeji Medical Center

Himeji-shi, Hyōgo, Japan

Site Status

Itami City Hospital

Itami-shi, Hyōgo, Japan

Site Status

Kobe City Medical Center General Hospital

Kobe, Hyōgo, Japan

Site Status

Kanazawa University Hospital

Kanazawa, Ishikawa-ken, Japan

Site Status

St Marianna University School of Medicine Hospital

Kawasaki-shi, Kanagawa, Japan

Site Status

Kitasato University Hospital

Sagamihara-shi, Kanagawa, Japan

Site Status

Kanagawa Prefectural Hospital Organization Kanagawa Cancer Center

Yokohama, Kanagawa, Japan

Site Status

Kyoto University Hospital

Kyoto, Kyoto, Japan

Site Status

Miyagi Cancer Center

Natori-shi, Miyagi, Japan

Site Status

Sendai Kousei Hospital

Sendai, Miyagi, Japan

Site Status

Niigata Cancer Center Hospital

Niigata, Niigata, Japan

Site Status

Okayama University Hospital

Okayama, Okayama-ken, Japan

Site Status

Osaka Habikino Medical Center

Habikino-shi, Osaka, Japan

Site Status

Kansai Medical University Hospital

Hirakata-shi, Osaka, Japan

Site Status

Osaka City General Hospital

Osaka, Osaka, Japan

Site Status

Osaka International Cancer Institute

Osaka, Osaka, Japan

Site Status

Kindai University Hospital

Osakasayama-shi, Osaka, Japan

Site Status

National Hospital Organization Kinki-chuo Chest Medical Center

Sakai-shi, Osaka, Japan

Site Status

Saga-ken Medical Centre Koseikan

Saga, Saga-ken, Japan

Site Status

Saitama Cancer Center

Kitaadachi-gun, Saitama, Japan

Site Status

Shiga University of Medical Science Hospital

Ōtsu, Shiga, Japan

Site Status

Juntendo University Hospital

Bunkyo-ku, Tokyo, Japan

Site Status

National Cancer Center Hospital

Chuo-ku, Tokyo, Japan

Site Status

Cancer Institute Hospital of Japanese Foundation for Cancer Research

Koto-ku, Tokyo, Japan

Site Status

Tottori University Hospital

Yonago-shi, Tottori, Japan

Site Status

Wakayama Medical University Hospital

Wakayama, Wakayama, Japan

Site Status

National Hospital Organization Iwakuni Clinical Center

Iwakuni-shi, Yamaguchi, Japan

Site Status

National Hospital Organization Yamaguchi Ube Medical Center

Ube-shi, Yamaguchi, Japan

Site Status

Nederlands Kanker Instituut Antoni van Leeuwenhoekziekenhuis

Amsterdam, , Netherlands

Site Status

Universitair Medisch Centrum Groningen

Groningen, , Netherlands

Site Status

Radboudumc

Nijmegen, , Netherlands

Site Status

Erasmus Medisch Centrum

Rotterdam, , Netherlands

Site Status

Universitair Medisch Centrum Utrecht

Utrecht, , Netherlands

Site Status

Uniwersyteckie Centrum Kliniczne

Gdansk, , Poland

Site Status

Instytut Genetyki i Immunologii GENIM Spzoo

Lublin, , Poland

Site Status

Szpital Kliniczny Przemienienia Panskiego Uniwersytetu Medycznego im K Marcinkowskiego w Poznaniu

Poznan, , Poland

Site Status

Centrum Onkologii Instytut im Marii Sklodowskiej-Curie

Warsaw, , Poland

Site Status

Dolnoslaskie Centrum Onkologii we Wroclawiu

Wroclaw, , Poland

Site Status

Centro Hospitalar Universitario de Lisboa Norte EPE - Hospital Pulido Valente

Lisbon, , Portugal

Site Status

Unidade Local de Saude de Matosinhos, EPE - Hospital Pedro Hispano

Matosinhos Municipality, , Portugal

Site Status

Centro Hospitalar Universitario do Porto EPE - Hospital de Santo Antonio

Porto, , Portugal

Site Status

Instituto Portugues de Oncologia do Porto Francisco Gentil, EPE

Porto, , Portugal

Site Status

Centro Hospitalar Universitario de Sao Joao EPE - Hospital Sao Joao

Porto, , Portugal

Site Status

Clinical hospital 2, Group of companies medsi

Moscow, , Russia

Site Status

LLC Tonus

Nizhny Novgorod, , Russia

Site Status

Omsk Regional Clinical Oncology Dispensary

Omsk, , Russia

Site Status

FSBI Scientific and Research Oncology Institute named after N N Petrov

Saint Petersburg, , Russia

Site Status

Saint Petersburg scientifical practical center of specialized kinds of medical care oncological

Saint Petersburg, , Russia

Site Status

Chungbuk National University Hospital

Cheongju-si, Chungcheongbuk-do, , South Korea

Site Status

National Cancer Center

Goyang-si Gyeonggi-do, , South Korea

Site Status

Cha Bundang Medical Center, Cha University

Seongnam-si, Gyeonggi-do, , South Korea

Site Status

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, , South Korea

Site Status

Seoul National University Hospital

Seoul, , South Korea

Site Status

Kangbuk Samsung Hospital

Seoul, , South Korea

Site Status

Severance Hospital Yonsei University Health System

Seoul, , South Korea

Site Status

Asan Medical Center

Seoul, , South Korea

Site Status

Samsung medical center

Seoul, , South Korea

Site Status

The Catholic University of Korea Seoul St Marys Hospital

Seoul, , South Korea

Site Status

Ulsan University Hospital

Ulsan, , South Korea

Site Status

Hospital Regional Universitario de Malaga

Málaga, AndalucÃ-a, Spain

Site Status

Hospital Universitario Insular de Gran Canaria

Las Palmas de Gran Canaria, Canary Islands, Spain

Site Status

Hospital Universitari Vall d Hebron

Barcelona, Cataluña, Spain

Site Status

Hospital Clinic i Provincial de Barcelona

Barcelona, Cataluña, Spain

Site Status

Hospital de la Santa Creu i Sant Pau

Barcelona, Cataluña, Spain

Site Status

Instituto Catalan de Oncologia Hospital Duran i Reynals

L'Hospitalet de Llobregat, Cataluña, Spain

Site Status

Complexo Hospitalario Universitario A Coruña Hospital Teresa Herrera

A Coruña, Galicia, Spain

Site Status

Hospital Universitario Puerta de Hierro Majadahonda

Majadahonda, Madrid, Spain

Site Status

Hospital Clinico Universitario de Valencia

Valencia, Valencia, Spain

Site Status

Hospital Universitario Ramon y Cajal

Madrid, , Spain

Site Status

Hospital Universitario 12 de Octubre

Madrid, , Spain

Site Status

Hospital Universitario La Paz

Madrid, , Spain

Site Status

Gavle Sjukhus

Gävle, , Sweden

Site Status

Sahlgrenska Universitetssjukhuset

Gothenburg, , Sweden

Site Status

Universitetssjukhuset i Linkoping

Linköping, , Sweden

Site Status

Skanes Universitetssjukhus

Lund, , Sweden

Site Status

Karolinska Universitetssjukhuset Solna

Stockholm, , Sweden

Site Status

Norrlands Universitetssjukhus

Umeå, , Sweden

Site Status

Universitaetsspital Basel

Basel, , Switzerland

Site Status

Inselspital Bern

Bern, , Switzerland

Site Status

Hopitaux Universitaires de Geneve

Geneva, , Switzerland

Site Status

Centre Hospitalier Universitaire Vaudois

Lausanne, , Switzerland

Site Status

Kantonsspital Winterthur

Winterthur, , Switzerland

Site Status

Universitaetsspital Zuerich

Zurich, , Switzerland

Site Status

China Medical University Hospital

Taichung, , Taiwan

Site Status

Veterans General Hospital - Taichung

Taichung, , Taiwan

Site Status

National Cheng Kung University Hospital

Tainan City, , Taiwan

Site Status

National Taiwan University Hospital

Taipei, , Taiwan

Site Status

Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust

Cambridge, , United Kingdom

Site Status

Western General Hospital

Edinburgh, , United Kingdom

Site Status

Royal Marsden Hospital

London, , United Kingdom

Site Status

Sarah Cannon Research Institute UK

London, , United Kingdom

Site Status

Christie Hospital

Manchester, , United Kingdom

Site Status

Nottingham City Hospital

Nottingham, , United Kingdom

Site Status

Churchill Hospital

Oxford, , United Kingdom

Site Status

Royal Marsden Hospital

Sutton, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Belgium Brazil Canada Denmark Finland France Germany Greece Hungary Italy Japan Netherlands Poland Portugal Russia South Korea Spain Sweden Switzerland Taiwan United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Waterhouse DM, Rothschild S, Dooms C, Mennecier B, Bozorgmehr F, Majem M, van den Heuvel MH, Linardou H, Chul Cho B, Roberts-Thomson R, Tanaka K, Blais N, Schvartsman G, Holmskov Hansen K, Chmielewska I, Forster MD, Giannopoulou C, Stollenwerk B, Obiozor CC, Wang Y, Novello S. Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation. Lung Cancer. 2024 Oct;196:107921. doi: 10.1016/j.lungcan.2024.107921. Epub 2024 Aug 6.

Reference Type BACKGROUND
PMID: 39303400 (View on PubMed)

Skoulidis F, Li BT, Hochmair M, Govindan R, Vincent M, van der Wekken AJ, Reguart Aransay N, O'Byrne KJ, Girard N, Griesinger F, Nishio M, Hafliger S, Lindsay C, Reinmuth N, Paulus A, Papakotoulas P, Kim SW, Ferreira CG, Pasello G, Duruisseaux M, Gennatas S, Dimou A, Mehta B, Kormany W, Nduka C, Sylvester BE, Ardito-Abraham C, Wang Y, de Langen AJ. Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancer. Oncologist. 2025 Jan 17;30(1):oyae356. doi: 10.1093/oncolo/oyae356.

Reference Type BACKGROUND
PMID: 39846981 (View on PubMed)

Skoulidis F, Li BT, de Langen AJ, Hong DS, Lena H, Wolf J, Dy GK, Curioni Fontecedro A, Tomasini P, Velcheti V, van der Wekken AJ, Dooms C, Paz-Ares Rodriguez L, Mountzios G, Sacher A, Nadal E, Couraud S, Kim SW, O'Byrne K, Rocco D, Toyozawa R, Chmielewska I, Lindsay CR, Hindoyan A, Mukundan L, Wilmanski T, Anderson A, Ardito-Abraham C, Pati A, Reddy A, Mehta B, Schuler M. Molecular determinants of sotorasib clinical efficacy in KRASG12C-mutated non-small-cell lung cancer. Nat Med. 2025 Aug;31(8):2755-2767. doi: 10.1038/s41591-025-03732-5. Epub 2025 May 28.

Reference Type BACKGROUND
PMID: 40437272 (View on PubMed)

de Langen AJ, Johnson ML, Mazieres J, Dingemans AC, Mountzios G, Pless M, Wolf J, Schuler M, Lena H, Skoulidis F, Yoneshima Y, Kim SW, Linardou H, Novello S, van der Wekken AJ, Chen Y, Peters S, Felip E, Solomon BJ, Ramalingam SS, Dooms C, Lindsay CR, Ferreira CG, Blais N, Obiozor CC, Wang Y, Mehta B, Varrieur T, Ngarmchamnanrith G, Stollenwerk B, Waterhouse D, Paz-Ares L; CodeBreaK 200 Investigators. Sotorasib versus docetaxel for previously treated KRAS G12C-mutated non-small-cell lung cancer: a plain language summary. Future Oncol. 2025 Apr;21(9):1033-1044. doi: 10.1080/14796694.2025.2474789. Epub 2025 Mar 24.

Reference Type BACKGROUND
PMID: 40129223 (View on PubMed)

Dingemans AC, Syrigos K, Livi L, Paulus A, Kim SW, Chen Y, Felip E, Griesinger F, Ohashi K, Zalcman G, Hughes BGM, Sorensen JB, Blais N, Ferreira CGM, Lindsay CR, Dziadziuszko R, Ward PJ, Obiozor CC, Wang Y, Peters S. Intracranial activity of sotorasib vs docetaxel in pretreated KRAS G12C-mutated advanced non-small cell lung cancer from a global, phase 3, randomized controlled trial. Lung Cancer. 2025 Sep;207:108683. doi: 10.1016/j.lungcan.2025.108683. Epub 2025 Jul 29.

Reference Type BACKGROUND
PMID: 40774040 (View on PubMed)

de Langen AJ, Johnson ML, Mazieres J, Dingemans AC, Mountzios G, Pless M, Wolf J, Schuler M, Lena H, Skoulidis F, Yoneshima Y, Kim SW, Linardou H, Novello S, van der Wekken AJ, Chen Y, Peters S, Felip E, Solomon BJ, Ramalingam SS, Dooms C, Lindsay CR, Ferreira CG, Blais N, Obiozor CC, Wang Y, Mehta B, Varrieur T, Ngarmchamnanrith G, Stollenwerk B, Waterhouse D, Paz-Ares L; CodeBreaK 200 Investigators. Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial. Lancet. 2023 Mar 4;401(10378):733-746. doi: 10.1016/S0140-6736(23)00221-0. Epub 2023 Feb 7.

Reference Type DERIVED
PMID: 36764316 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Related Links

Access external resources that provide additional context or updates about the study.

http://www.amgentrials.com

AmgenTrials clinical trials website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-508214-42-00

Identifier Type: OTHER

Identifier Source: secondary_id

20190009

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.